Dr Louise Sigfrid
ERGO Clinical Research Fellow
Louise Sigfrid is a Clinical Research Fellow and Public Health Specialist, with a main focus to strengthen preparedness to (re-) emerging infectious diseases through clinical research and capacity building.
Louise main focus is the PREPARE (Platform for European Preparedness Against (Re-) emerging Epidemics) project, studying incidence risk factors and clinical impact of infections with epidemic potential in Europe with a focus on acute respiratory infections, central nervous system infections, arbovirus and haemorrhagic fever syndromes in hospitalized and primary care patients.
Additionally, Louise supports the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) developing harmonised clinical research tools for characterization of emerging infections globally, including COVID-19.
Louise is lead for the Masters module in Health Protection at Brighton & Sussex Medical School and Honorary Academic Public Health Consultant at PHE.
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
Sigfrid L. et al, (2021)
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
Sigfrid L. et al, (2021), BMJ Open, 11, e043887 - e043887
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.
Gupta RK. et al, (2021), The Lancet. Respiratory medicine
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
Drake TM. et al, (2020), American Journal of Respiratory and Critical Care Medicine, 202, 1656 - 1665
What are the long-term symptoms and complications of COVID-19: A protocol for a living systematic review
Michelen M. et al, (2020), F1000Research, 9